Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GHRH: Cognition in Aging and MCI.

Trial Profile

GHRH: Cognition in Aging and MCI.

Phase of Trial: Phase II

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Tesamorelin (Primary)
  • Indications Mild cognitive impairment
  • Focus Therapeutic Use
  • Acronyms SMART
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Dec 2013 NCT reports actual patient number as 151.
    • 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top